Literature DB >> 3517029

Type I diabetes is characterized by insulin resistance not only with regard to glucose, but also to lipid and amino acid metabolism.

R Trevisan, R Nosadini, A Avogaro, G Lippe, E Duner, P Fioretto, R Deana, P Tessari, A Tiengo, M Velussi.   

Abstract

Resistance to the metabolic effects of insulin has been reported with regard to glucose disposal in type I diabetic patients (IDDM) even when they were euglycemic. Our aim was to study glucose, lipid, and amino acid metabolism during glucose clamping at multiple levels of insulin in 10 normal (N) and 6 IDDM patients. Blood glucose was maintained constant (4.7 mmol/liter) at three insulin plateaus (160 min each) [42 +/- 6 (SD) 89 +/- 11, and 1255 +/- 185 microU/ml in N and 36 +/- 4, 80 +/- 13, and 1249 +/- 107 microU/liter in IDDM]. Mean glucose disposal was 34 +/- 11, 69 +/- 10, and 84 +/- 22 mumol kg-1 min-1 in N and 16 +/- 5, 40 +/- 18, and 65 +/- 27 in IDDM, respectively. Baseline concentrations of blood lactate, pyruvate, alanine, and branched chain amino acids were 560 +/- 130, 36 +/- 9, 212 +/- 44, and 451 +/- 19 mumol/liter, in N and 793 +/- 179 (P less than 0.05), 45 +/- 14, 195 +/- 50, and 439 +/- 33 in IDDM, respectively. The maximum percent change of lactate during the euglycemic clamp was +147 +/- 23% in N and +75 +/- 15% (P less than 0.05) in IDDM; that of branched chain amino acids was -61 +/- 5% in N and -48 +/- 7% (P less than 0.01) in IDDM. Baseline concentrations of glycerol, FFA, and adipate were 44 +/- 15, 449 +/- 152, and 8 - 8 mumol/liter in N and 39 +/- 14, 473 +/- 44, and 41 +/- 14 (P less than 0.01) in IDDM. The maximum percent change of glycerol during the euglycemic clamp was -50 +/- 8% in N and -16 +/- 8% (P less than 0.01) in IDDM, that of FFA -98 +/- 3% in N and -70 +/- 4% in IDDM (P less than 0.05). No significant differences were found between N and IDDM with regard to blood concentrations of ketone bodies, citrate, ketoglutarate, and hydroxymethylglutaryl coenzyme A both before and during the euglycemic clamp. The lactate percent increase was significantly correlated to glucose disposal rate (P less than 0.001). The lactate turnover rate increased during the euglycemic clamp and was lower in IDDM than in N. We conclude that during euglycemic-multiple insulin clamp studies the greater lactate increase suggests that the flux of glycolysis is higher in N than in IDDM, tricarboxylic acid concentrations are comparable in N and IDDM, and FFA, glycerol, and branched chain amino acid decreases were less in IDDM than in N, suggesting that IDDM patients are resistant to insulin with regard to lipid and protein metabolism. The higher adipate basal values demonstrate enhanced omega-oxidation in IDDM.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3517029     DOI: 10.1210/jcem-62-6-1155

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  12 in total

1.  Intracellular lactate- and pyruvate-interconversion rates are increased in muscle tissue of non-insulin-dependent diabetic individuals.

Authors:  A Avogaro; G Toffolo; M Miola; A Valerio; A Tiengo; C Cobelli; S Del Prato
Journal:  J Clin Invest       Date:  1996-07-01       Impact factor: 14.808

2.  Blood lactate behavior after glucose load in diabetes mellitus.

Authors:  R Prando; V Cheli; P Buzzo; P Melga; E Ansaldi; S Accoto
Journal:  Acta Diabetol Lat       Date:  1988 Jul-Sep

3.  Insulin sensitivity index in type 1 diabetes and following human islet transplantation: comparison of the minimal model to euglycemic clamp measures.

Authors:  Michael R Rickels; Stephanie M Kong; Carissa Fuller; Cornelia Dalton-Bakes; Jane F Ferguson; Muredach P Reilly; Karen L Teff; Ali Naji
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-04-01       Impact factor: 4.310

4.  Effects of acute systemic hyperinsulinemia on forearm muscle proteolysis in healthy man.

Authors:  P Tessari; S Inchiostro; G Biolo; E Vincenti; L Sabadin
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

Review 5.  The physiological basis of insulin treatment--clinical aspects.

Authors:  W K Waldhäusl
Journal:  Diabetologia       Date:  1986-12       Impact factor: 10.122

Review 6.  Pancreatic Islet Transplantation in Humans: Recent Progress and Future Directions.

Authors:  Michael R Rickels; R Paul Robertson
Journal:  Endocr Rev       Date:  2019-04-01       Impact factor: 19.871

7.  Effect of insulin on human adipose tissue metabolism in situ. Interactions with beta-adrenoceptors.

Authors:  E Hagström-Toft; P Arner; U Johansson; L S Eriksson; U Ungerstedt; J Bolinder
Journal:  Diabetologia       Date:  1992-07       Impact factor: 10.122

8.  Improvement in insulin sensitivity after human islet transplantation for type 1 diabetes.

Authors:  Michael R Rickels; Stephanie M Kong; Carissa Fuller; Cornelia Dalton-Bakes; Jane F Ferguson; Muredach P Reilly; Karen L Teff; Ali Naji
Journal:  J Clin Endocrinol Metab       Date:  2013-10-01       Impact factor: 5.958

9.  Metabolomic analysis of rat serum in streptozotocin-induced diabetes and after treatment with oral triethylenetetramine (TETA).

Authors:  Marta Ugarte; Marie Brown; Katherine A Hollywood; Garth J Cooper; Paul N Bishop; Warwick B Dunn
Journal:  Genome Med       Date:  2012-04-30       Impact factor: 11.117

10.  A systems view of type 2 diabetes-associated metabolic perturbations in saliva, blood and urine at different timescales of glycaemic control.

Authors:  Noha A Yousri; Dennis O Mook-Kanamori; Mohammed M El-Din Selim; Ahmed H Takiddin; Hala Al-Homsi; Khoulood A S Al-Mahmoud; Edward D Karoly; Jan Krumsiek; Kieu Trinh Do; Kieu Thinh Do; Ulrich Neumaier; Marjonneke J Mook-Kanamori; Jillian Rowe; Omar M Chidiac; Cindy McKeon; Wadha A Al Muftah; Sara Abdul Kader; Gabi Kastenmüller; Karsten Suhre
Journal:  Diabetologia       Date:  2015-06-07       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.